Medicare billing address
CMS Medicare provider billing file
760 W Sproul Rd Ste 200Springfield, PA 19064
CMS public data · NPI 1770704850
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
John Godfrey, D.O.
Specialty
Credential
D.O.
NPI
1770704850
Primary source state
PA
Data retrieval date
July 26, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for John Godfrey, D.O. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
760 W Sproul Rd Ste 200CMS Doctors & Clinicians file
125 Medical Campus DrCMS Doctors & Clinicians file
1703 S Broad StCMS Doctors & Clinicians file
404 Mcfarlan RdIn the 2024 CMS provider billing file, this NPI had 1,957 Medicare beneficiaries and 5,775 total services. The average beneficiary age was 75, and the average HCC risk score was 1.9.
Total Medicare allowed amount
$917,478.06
Total Medicare payment amount
$723,532.01
Medicare beneficiaries
1,957
Total services
5,775
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
51%
CMS beneficiary-panel share
Diabetes
40%
CMS beneficiary-panel share
Atrial fibrillation
37%
CMS beneficiary-panel share
Heart failure
37%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,318 | $8.68 |
| Injection, regadenoson, 0.1 mg | 678 | $3.06 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 628 | $138.05 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 573 | $17.65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 570 | $15.55 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 326 | $84.53 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 189 | $72.75 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 183 | $211.69 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 174 | $76.24 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 158 | $776.75 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1770704850. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Atorvastatin Calcium | Atorvastatin Calcium | 641 | 1,421.2 | $7,166.89 |
| 2 | Metoprolol Succinate | Metoprolol Succinate | 472 | 1,041.6 | $6,093.58 |
| 3 | Eliquis | Apixaban | 315 | 493 | $281,388.93 |
| 4 | Amlodipine Besylate | Amlodipine Besylate | 257 | 535.3 | $1,538.08 |
| 5 | Furosemide | Furosemide | 249 | 493.3 | $928.01 |
| 6 | Ezetimibe | Ezetimibe | 243 | 537 | $5,797.26 |
| 7 | Carvedilol | Carvedilol | 227 | 453.5 | $1,948.72 |
| 8 | Rosuvastatin Calcium | Rosuvastatin Calcium | 203 | 452.6 | $3,326.55 |
| 9 | Entresto | Sacubitril/Valsartan | 202 | 320.3 | $209,398.39 |
| 10 | Lisinopril | Lisinopril | 168 | 376 | $1,014.11 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Kansas City University Of Med & Biosciences, College Of Osteo Med
Graduation year
2001
Group/practice field
Cardiology Consultants Of Philadelphia Pc
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Internal Medicine.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.